Skip to main content
Premium Trial:

Request an Annual Quote

Millipore Prices Previously Disclosed $550M Offering

NEW YORK, June 7 (GenomeWeb News) - Millipore will offer $550 million of convertible senior notes with 3.75 percent annual interest, the company said today.

As GenomeWeb News reported yesterday, the Billerica, Mass.-based company will use the funds to finance its acquisition of Serologicals.

As previously reported, the notes will be convertible into cash and shares of Millipore's common stock. The initial conversion rate is 11.0485 shares per $1,000 principal amount of notes, representing an initial conversion price of approximately $90.51 per share.

The sale of the notes is expected to close on June 13.

The Scan

Review of Approval Process

Stat News reports the Department for Health and Human Services' Office of the Inspector General is to investigate FDA's approval of Biogen's Alzheimer's disease drug.

Not Quite Right

A new analysis has found hundreds of studies with incorrect nucleotide sequences reported in their methods, according to Nature News.

CRISPR and mRNA Together

Time magazine reports on the use of mRNA to deliver CRISPR machinery.

Nature Papers Present Smartphone Platform for DNA Diagnosis of Malaria, Mouse Lines for Epigenomic Editing

In Nature this week: a low-cost tool to detect infectious diseases like malaria, and more.